NPPA issued a notification regarding the Dapagliflozin Propanediol USP

Oct 06, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on October 03, 2024, issued a notification regarding the fixation of the retail price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2mg + Metformin Hydrochloride IP 500mg.

The following has been stated: -

•For each Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2mg + Metformin Hydrochloride IP 500mg (as Extended release) for M/s Mascot Health Series Pvt Ltd. (Manufacturer) & M/s Alembic Pharmaceuticals Ltd (Marketer) the retail price is 12.42.

The detailed notification is given in the document attached below.

[Notification No. 19(4230)/2024/DP/NPPA/DIV.II] 


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT